We monitor closely during the first three months when side effects peak, adjusting protocols based on individual response
The most radical solution was adopted by the company Intarcia, whose product Itca 650 comprises exenatide administered in an osmotic minipump the size of a match, and similar to those used for animals, but capable of providing a constant delivery of exenatide for 612 months after subcutaneous implantation (117)
The HPLC data matched our independent verification
This four-day series presents a blend of interventions, including IV therapies, participants can tailor to suit their preferences
Another drug that may be used to treat CINV in some cases is megestrol acetate (Megace), a synthetic progesterone derivative
TrulicityTM: summary of product characteristics